The first patient has been dosed in a Phase 1 clinical trial of Autolus Therapeutics‘ experimental CAR T-cell therapy, obecabtagene autoleucel (obe-cel), in people with progressive forms of multiple sclerosis […]
The post 1st MS patient dosed with Autolus’ CAR T-cell therapy in Phase 1 trial appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com